Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Replimune Group Inc is listed on the CBOE trading with ticker code REPL.US. It has a market capitalisation of $812.59m, with approximately 83.95m shares in issue. Over the last year, Replimune Group ...
Millions of children will grab lunchboxes, backpacks and rolling bags and head to their first day of kindergarten this year. Some will go for a half day and some for a full. Some will attend private ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results